MolecuLight most recent study on Medical Imaging device

January 15 2018

The Journal of Wound Care

Current standard diagnostic practice of bacterial infections by visual inspection under white light is subjective, and microbiological sampling is suboptimal due to high false negative rates and the lengthy time needed for culture results to arrive. The MolecuLight i:X Imaging Device attempts to combat the issues faced in standard practice by providing a non-contact, real-time method of visualising bacteria within wounds. Our aim was to test this imaging device in a series of patients.

(Read more …) 

About

  • iGan Partners is Canada's early-stage health technology venture capital firm investing in inspiring entrepreneurs to commercialise and scale their disruptive innovations.

Copyright © 2018 iGan Partners